These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro. Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621 [TBL] [Abstract][Full Text] [Related]
9. Novel 1,2-dihydroquinazolin-2-ones: Design, synthesis, and biological evaluation against Trypanosoma brucei. Pham T; Walden M; Butler C; Diaz-Gonzalez R; Pérez-Moreno G; Ceballos-Pérez G; Gomez-Pérez V; García-Hernández R; Zecca H; Krakoff E; Kopec B; Ichire O; Mackenzie C; Pitot M; Ruiz LM; Gamarro F; González-Pacanowska D; Navarro M; Dounay AB Bioorg Med Chem Lett; 2017 Aug; 27(16):3629-3635. PubMed ID: 28729055 [TBL] [Abstract][Full Text] [Related]
10. Depletion of the extracellular-signal regulated kinase 8 homolog in Trypanosoma brucei in vivo reduces its virulence in a mouse target validation study. Elaadli H; Kim I; Mackey ZB Mol Biochem Parasitol; 2018 Mar; 220():1-4. PubMed ID: 29287675 [TBL] [Abstract][Full Text] [Related]
11. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors. Demir O; Labaied M; Merritt C; Stuart K; Amaro RE Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413 [TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign. Diaz R; Luengo-Arratta SA; Seixas JD; Amata E; Devine W; Cordon-Obras C; Rojas-Barros DI; Jimenez E; Ortega F; Crouch S; Colmenarejo G; Fiandor JM; Martin JJ; Berlanga M; Gonzalez S; Manzano P; Navarro M; Pollastri MP PLoS Negl Trop Dis; 2014 Oct; 8(10):e3253. PubMed ID: 25340575 [TBL] [Abstract][Full Text] [Related]
13. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent. Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness. Bland ND; Wang C; Tallman C; Gustafson AE; Wang Z; Ashton TD; Ochiana SO; McAllister G; Cotter K; Fang AP; Gechijian L; Garceau N; Gangurde R; Ortenberg R; Ondrechen MJ; Campbell RK; Pollastri MP J Med Chem; 2011 Dec; 54(23):8188-94. PubMed ID: 22023548 [TBL] [Abstract][Full Text] [Related]
15. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis. Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695 [TBL] [Abstract][Full Text] [Related]
16. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei. Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Antiplasmodial 2-Aminopyridines as Potential Antitrypanosomal Agents. Veale CGL; Laming D; Swart T; Chibale K; Hoppe HC ChemMedChem; 2019 Dec; 14(24):2034-2041. PubMed ID: 31670464 [TBL] [Abstract][Full Text] [Related]
18. Whole-organism high-throughput screening against Trypanosoma brucei brucei. Jones AJ; Avery VM Expert Opin Drug Discov; 2013 May; 8(5):495-507. PubMed ID: 23540598 [TBL] [Abstract][Full Text] [Related]
19. Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei. Sun YN; No JH; Lee GY; Li W; Yang SY; Yang G; Schmidt TJ; Kang JS; Kim YH Molecules; 2016 Apr; 21(4):480. PubMed ID: 27077842 [TBL] [Abstract][Full Text] [Related]
20. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay. Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]